Frontiers in Oncology (Jun 2021)

RNA N6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications

  • Qin Dang,
  • Bo Shao,
  • Bo Shao,
  • Quanbo Zhou,
  • Chen Chen,
  • Chen Chen,
  • Yaxin Guo,
  • Yaxin Guo,
  • Yaxin Guo,
  • Guixian Wang,
  • Jinbo Liu,
  • Quancheng Kan,
  • Weitang Yuan,
  • Zhenqiang Sun

DOI
https://doi.org/10.3389/fonc.2021.681781
Journal volume & issue
Vol. 11

Abstract

Read online

Cancer metastasis is a symptom of adverse prognosis, a prime origin of therapy failure, and a lethal challenge for cancer patients. N6-methyladenosine (m6A), the most prevailing modification in messenger RNAs (mRNAs) and non-coding RNAs (ncRNAs) of higher eukaryotes, has attracted increasing attention. Growing studies have verified the pivotal roles of m6A methylation in controlling mRNAs and ncRNAs in diverse physiological processes. Remarkably, recent findings have showed that aberrant methylation of m6A-related RNAs could influence cancer metastasis. In this review, we illuminate how m6A modifiers act on mRNAs and ncRNAs and modulate metastasis in several cancers, and put forward the clinical application prospects of m6A methylation.

Keywords